You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC ○

found 2026 › Jun › 16 (Tue) @ 05:13 UTC

Biopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.